Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$135,000.00
Apr 1, 2012
Transcriptomic and proteomic screening of host genes modulated by HIV-1 in human macrophages : a highly sensitive strategy for the identification of new susceptibility/restriction factors.
$231,333.00
Apr 1, 2012
Experimental Therapies to prevent pulmonary hypertension and promote lung vascular growth in congenital diaphragmatic hernia
$103,350.00
Apr 1, 2012
The association of serum Vitamin D levels, genetic variants in vitamin D metabolism genes and pancreatic cancer risk.
$549,872.00
Apr 1, 2012
Integration of mTOR-p53 pathway crosstalk and miR-34 family in prognostication and prediction of response to bladder cancer therapy
$99,961.00
Apr 1, 2012
Efficacy of combination therapy with intravenous ketorolac and metoclopramide for pediatric migraine therapy in the Emergency Department - a randomized placebo controlled trial.
$459,909.00
Apr 1, 2012
Anomia in Alzheimer's Disease: Untangling semantic components and delivering therapy with rTMS.
$140,000.00
Apr 1, 2012
The effect that inactivation of the RNA interference machinery has on endogenous levels of microRNAs and their gene targets
$199,080.00
Apr 1, 2012
Development, Implementation and Dissemination of a Standardized Approach to the Care of Paediatric Multiple Sclerosis: A National Consensus Guideline of Management Strategies including Treatment of Acute Relapses, Immunomodulation and Escalation Therapy to Increase Patient Safety and Prevent Early-Onset Neurological Disability
$54,650.00
Apr 1, 2012
The impact of 3D nuclear chromosome and gene positions on cancer
$78,750.00
Apr 1, 2012
Structure and function of polynucleotide kinase/phosphatase, a potential target in cancer therapy.